InvestorsHub Logo
Followers 4
Posts 103
Boards Moderated 0
Alias Born 01/06/2015

Re: Mccpingins post# 5856

Tuesday, 07/12/2016 8:51:40 AM

Tuesday, July 12, 2016 8:51:40 AM

Post# of 83344
I don't have an issue with the compensation program at all. If you look at the deal they are not getting the options until they complete certain criteria.

Basically, this as I see it, is totally incentive based as well it should be. I think that when the company gets the ball rolling with the FDA with respect to its CBD processing and formula applications, it then will position itself very nicely for an acquisition or merger.

Their CBD oil is of extremely high quality, and very likely will (if not already) attract other major players in the Big Pharm space.

One of the pivotal keys to all of this is to get the DEA to reschedule marijuana to Schedule 2 status. Then the CBD research market can get going and thats where the home run will be.

The election this year is very critical for these types of things. Getting more states to recognize the value of commercializing marijuana, and its value as a taxable commodity also will play big.

The other key is what type of new administration is in the White House. Those who follow politics know that Clinton is far more relaxed about marijuana and its handling on a state by state basis.

Trump on the other hand also has no problem with it on a state basis. However, if he chooses Christie as a running mate and wins, the whole marijuana industry will definitely be stonewalled.

Christie as those who know him is very anti marijuana. Including research for medical purposes.